nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.034	0.0437	CbGbCtD
Ifosfamide—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0236	0.0303	CbGbCtD
Ifosfamide—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0224	0.0287	CbGbCtD
Ifosfamide—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0221	0.0284	CbGbCtD
Ifosfamide—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0221	0.0284	CbGbCtD
Ifosfamide—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.021	0.027	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.021	0.027	CbGbCtD
Ifosfamide—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.02	0.0257	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0233	CbGbCtD
Ifosfamide—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0233	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0226	CbGbCtD
Ifosfamide—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0176	0.0226	CbGbCtD
Ifosfamide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0174	0.0224	CbGbCtD
Ifosfamide—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0168	0.0216	CbGbCtD
Ifosfamide—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0205	CbGbCtD
Ifosfamide—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0205	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0205	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0205	CbGbCtD
Ifosfamide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0158	0.0203	CbGbCtD
Ifosfamide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0158	0.0203	CbGbCtD
Ifosfamide—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0152	0.0195	CbGbCtD
Ifosfamide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0152	0.0195	CbGbCtD
Ifosfamide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0152	0.0195	CbGbCtD
Ifosfamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.015	0.0192	CbGbCtD
Ifosfamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0141	0.0181	CbGbCtD
Ifosfamide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0175	CbGbCtD
Ifosfamide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.017	CbGbCtD
Ifosfamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0127	0.0163	CbGbCtD
Ifosfamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0127	0.0163	CbGbCtD
Ifosfamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0124	0.016	CbGbCtD
Ifosfamide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0154	CbGbCtD
Ifosfamide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0154	CbGbCtD
Ifosfamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0117	0.015	CbGbCtD
Ifosfamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0117	0.015	CbGbCtD
Ifosfamide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0115	0.0148	CbGbCtD
Ifosfamide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0115	0.0148	CbGbCtD
Ifosfamide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.011	0.0142	CbGbCtD
Ifosfamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.011	0.0141	CbGbCtD
Ifosfamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0137	CbGbCtD
Ifosfamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0136	CbGbCtD
Ifosfamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0106	0.0136	CbGbCtD
Ifosfamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00964	0.0124	CbGbCtD
Ifosfamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00964	0.0124	CbGbCtD
Ifosfamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00925	0.0119	CbGbCtD
Ifosfamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00913	0.0117	CbGbCtD
Ifosfamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00887	0.0114	CbGbCtD
Ifosfamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00802	0.0103	CbGbCtD
Ifosfamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00802	0.0103	CbGbCtD
Ifosfamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00769	0.00987	CbGbCtD
Ifosfamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00724	0.00929	CbGbCtD
Ifosfamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0068	0.00874	CbGbCtD
Ifosfamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0068	0.00874	CbGbCtD
Ifosfamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00615	0.0079	CbGbCtD
Ifosfamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00615	0.0079	CbGbCtD
Ifosfamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00531	0.00682	CbGbCtD
Ifosfamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00516	0.00662	CbGbCtD
Ifosfamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00466	0.00599	CbGbCtD
Ifosfamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00466	0.00599	CbGbCtD
Ifosfamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00447	0.00574	CbGbCtD
Ifosfamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000958	0.054	CbGeAlD
Ifosfamide—CYP2C18—digestive system—acquired immunodeficiency syndrome	0.000867	0.0488	CbGeAlD
Ifosfamide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000836	0.0471	CbGeAlD
Ifosfamide—CYP2C18—vagina—acquired immunodeficiency syndrome	0.000766	0.0431	CbGeAlD
Ifosfamide—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000764	0.043	CbGeAlD
Ifosfamide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000755	0.0425	CbGeAlD
Ifosfamide—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00075	0.0423	CbGeAlD
Ifosfamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000743	0.0418	CbGeAlD
Ifosfamide—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000678	0.0382	CbGeAlD
Ifosfamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000567	0.0319	CbGeAlD
Ifosfamide—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000506	0.0285	CbGeAlD
Ifosfamide—CYP2A6—lung—acquired immunodeficiency syndrome	0.000479	0.027	CbGeAlD
Ifosfamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000369	0.0208	CbGeAlD
Ifosfamide—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000361	0.0203	CbGeAlD
Ifosfamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000351	0.0198	CbGeAlD
Ifosfamide—CYP2A6—brain—acquired immunodeficiency syndrome	0.000339	0.0191	CbGeAlD
Ifosfamide—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000326	0.0184	CbGeAlD
Ifosfamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000325	0.0183	CbGeAlD
Ifosfamide—CYP2C8—blood—acquired immunodeficiency syndrome	0.000306	0.0173	CbGeAlD
Ifosfamide—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000292	0.0165	CbGeAlD
Ifosfamide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00029	0.0164	CbGeAlD
Ifosfamide—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000289	0.0163	CbGeAlD
Ifosfamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000286	0.0161	CbGeAlD
Ifosfamide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000284	0.016	CbGeAlD
Ifosfamide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000277	0.0156	CbGeAlD
Ifosfamide—CYP2B6—blood—acquired immunodeficiency syndrome	0.000275	0.0155	CbGeAlD
Ifosfamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000272	0.0153	CbGeAlD
Ifosfamide—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000261	0.0147	CbGeAlD
Ifosfamide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000256	0.0144	CbGeAlD
Ifosfamide—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000255	0.0144	CbGeAlD
Ifosfamide—PTGS1—blood—acquired immunodeficiency syndrome	0.000248	0.014	CbGeAlD
Ifosfamide—CYP3A5—lung—acquired immunodeficiency syndrome	0.000242	0.0137	CbGeAlD
Ifosfamide—CYP2B6—lung—acquired immunodeficiency syndrome	0.000241	0.0136	CbGeAlD
Ifosfamide—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000239	0.0135	CbGeAlD
Ifosfamide—PTGS1—vagina—acquired immunodeficiency syndrome	0.00023	0.013	CbGeAlD
Ifosfamide—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000223	0.0126	CbGeAlD
Ifosfamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000218	0.0123	CbGeAlD
Ifosfamide—PTGS1—lung—acquired immunodeficiency syndrome	0.000218	0.0123	CbGeAlD
Ifosfamide—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000215	0.0121	CbGeAlD
Ifosfamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000208	0.0117	CbGeAlD
Ifosfamide—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000202	0.0114	CbGeAlD
Ifosfamide—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000194	0.0109	CbGeAlD
Ifosfamide—CYP2C8—brain—acquired immunodeficiency syndrome	0.00019	0.0107	CbGeAlD
Ifosfamide—CYP2B6—brain—acquired immunodeficiency syndrome	0.000171	0.00961	CbGeAlD
Ifosfamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000168	0.00949	CbGeAlD
Ifosfamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000162	0.00914	CbGeAlD
Ifosfamide—PTGS1—brain—acquired immunodeficiency syndrome	0.000154	0.00868	CbGeAlD
Ifosfamide—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000149	0.00839	CbGeAlD
Ifosfamide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000514	CcSEcCtD
Ifosfamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000512	CcSEcCtD
Ifosfamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000104	0.000511	CcSEcCtD
Ifosfamide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000511	CcSEcCtD
Ifosfamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000511	CcSEcCtD
Ifosfamide—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000511	CcSEcCtD
Ifosfamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000104	0.000511	CcSEcCtD
Ifosfamide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000508	CcSEcCtD
Ifosfamide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000507	CcSEcCtD
Ifosfamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000506	CcSEcCtD
Ifosfamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000506	CcSEcCtD
Ifosfamide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000506	CcSEcCtD
Ifosfamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000505	CcSEcCtD
Ifosfamide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000505	CcSEcCtD
Ifosfamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000504	CcSEcCtD
Ifosfamide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000504	CcSEcCtD
Ifosfamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000503	CcSEcCtD
Ifosfamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000503	CcSEcCtD
Ifosfamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000502	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.0005	CcSEcCtD
Ifosfamide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000499	CcSEcCtD
Ifosfamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000499	CcSEcCtD
Ifosfamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000499	CcSEcCtD
Ifosfamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000101	0.000498	CcSEcCtD
Ifosfamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000497	CcSEcCtD
Ifosfamide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000497	CcSEcCtD
Ifosfamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000496	CcSEcCtD
Ifosfamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000496	CcSEcCtD
Ifosfamide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000496	CcSEcCtD
Ifosfamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000496	CcSEcCtD
Ifosfamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000494	CcSEcCtD
Ifosfamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000494	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000493	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.0001	0.000491	CcSEcCtD
Ifosfamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.99e-05	0.00049	CcSEcCtD
Ifosfamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.99e-05	0.00049	CcSEcCtD
Ifosfamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.99e-05	0.00049	CcSEcCtD
Ifosfamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.99e-05	0.00049	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.98e-05	0.00049	CcSEcCtD
Ifosfamide—Cough—Saquinavir—acquired immunodeficiency syndrome	9.97e-05	0.000489	CcSEcCtD
Ifosfamide—Angioedema—Lamivudine—acquired immunodeficiency syndrome	9.96e-05	0.000489	CcSEcCtD
Ifosfamide—Constipation—Indinavir—acquired immunodeficiency syndrome	9.91e-05	0.000486	CcSEcCtD
Ifosfamide—Pain—Indinavir—acquired immunodeficiency syndrome	9.91e-05	0.000486	CcSEcCtD
Ifosfamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.9e-05	0.000486	CcSEcCtD
Ifosfamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.9e-05	0.000486	CcSEcCtD
Ifosfamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.86e-05	0.000484	CcSEcCtD
Ifosfamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.85e-05	0.000483	CcSEcCtD
Ifosfamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.85e-05	0.000483	CcSEcCtD
Ifosfamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.84e-05	0.000483	CcSEcCtD
Ifosfamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.83e-05	0.000483	CcSEcCtD
Ifosfamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.83e-05	0.000482	CcSEcCtD
Ifosfamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.81e-05	0.000481	CcSEcCtD
Ifosfamide—Nausea—Didanosine—acquired immunodeficiency syndrome	9.81e-05	0.000481	CcSEcCtD
Ifosfamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.79e-05	0.000481	CcSEcCtD
Ifosfamide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.79e-05	0.00048	CcSEcCtD
Ifosfamide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.77e-05	0.000479	CcSEcCtD
Ifosfamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.76e-05	0.000479	CcSEcCtD
Ifosfamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.76e-05	0.000479	CcSEcCtD
Ifosfamide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.000478	CcSEcCtD
Ifosfamide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.73e-05	0.000477	CcSEcCtD
Ifosfamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.73e-05	0.000477	CcSEcCtD
Ifosfamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.73e-05	0.000477	CcSEcCtD
Ifosfamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.69e-05	0.000475	CcSEcCtD
Ifosfamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.66e-05	0.000474	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.66e-05	0.000474	CcSEcCtD
Ifosfamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.61e-05	0.000472	CcSEcCtD
Ifosfamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.55e-05	0.000469	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.54e-05	0.000468	CcSEcCtD
Ifosfamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.52e-05	0.000467	CcSEcCtD
Ifosfamide—Cough—Lamivudine—acquired immunodeficiency syndrome	9.51e-05	0.000467	CcSEcCtD
Ifosfamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.51e-05	0.000467	CcSEcCtD
Ifosfamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000466	CcSEcCtD
Ifosfamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000466	CcSEcCtD
Ifosfamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.48e-05	0.000465	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.48e-05	0.000465	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.45e-05	0.000464	CcSEcCtD
Ifosfamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.44e-05	0.000463	CcSEcCtD
Ifosfamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.44e-05	0.000463	CcSEcCtD
Ifosfamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.44e-05	0.000463	CcSEcCtD
Ifosfamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.41e-05	0.000462	CcSEcCtD
Ifosfamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.000462	CcSEcCtD
Ifosfamide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000461	CcSEcCtD
Ifosfamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.37e-05	0.00046	CcSEcCtD
Ifosfamide—Pain—Efavirenz—acquired immunodeficiency syndrome	9.36e-05	0.00046	CcSEcCtD
Ifosfamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.36e-05	0.00046	CcSEcCtD
Ifosfamide—Rash—Nevirapine—acquired immunodeficiency syndrome	9.36e-05	0.000459	CcSEcCtD
Ifosfamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.35e-05	0.000459	CcSEcCtD
Ifosfamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.34e-05	0.000458	CcSEcCtD
Ifosfamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.34e-05	0.000458	CcSEcCtD
Ifosfamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.32e-05	0.000458	CcSEcCtD
Ifosfamide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.000457	CcSEcCtD
Ifosfamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.28e-05	0.000455	CcSEcCtD
Ifosfamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.28e-05	0.000455	CcSEcCtD
Ifosfamide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.28e-05	0.000455	CcSEcCtD
Ifosfamide—Infection—Saquinavir—acquired immunodeficiency syndrome	9.26e-05	0.000455	CcSEcCtD
Ifosfamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.23e-05	0.000453	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000452	CcSEcCtD
Ifosfamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.21e-05	0.000452	CcSEcCtD
Ifosfamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.00045	CcSEcCtD
Ifosfamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.16e-05	0.00045	CcSEcCtD
Ifosfamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.16e-05	0.00045	CcSEcCtD
Ifosfamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.14e-05	0.000449	CcSEcCtD
Ifosfamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.14e-05	0.000449	CcSEcCtD
Ifosfamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000448	CcSEcCtD
Ifosfamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.12e-05	0.000447	CcSEcCtD
Ifosfamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.11e-05	0.000447	CcSEcCtD
Ifosfamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.07e-05	0.000445	CcSEcCtD
Ifosfamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.06e-05	0.000445	CcSEcCtD
Ifosfamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.06e-05	0.000445	CcSEcCtD
Ifosfamide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.05e-05	0.000444	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.04e-05	0.000444	CcSEcCtD
Ifosfamide—Rash—Stavudine—acquired immunodeficiency syndrome	9.04e-05	0.000444	CcSEcCtD
Ifosfamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.03e-05	0.000443	CcSEcCtD
Ifosfamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.03e-05	0.000443	CcSEcCtD
Ifosfamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.02e-05	0.000443	CcSEcCtD
Ifosfamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.01e-05	0.000442	CcSEcCtD
Ifosfamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.98e-05	0.000441	CcSEcCtD
Ifosfamide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.00044	CcSEcCtD
Ifosfamide—Pain—Delavirdine—acquired immunodeficiency syndrome	8.96e-05	0.00044	CcSEcCtD
Ifosfamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.96e-05	0.00044	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.95e-05	0.000439	CcSEcCtD
Ifosfamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.94e-05	0.000439	CcSEcCtD
Ifosfamide—Rash—Abacavir—acquired immunodeficiency syndrome	8.91e-05	0.000437	CcSEcCtD
Ifosfamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.9e-05	0.000437	CcSEcCtD
Ifosfamide—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.000437	CcSEcCtD
Ifosfamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.000437	CcSEcCtD
Ifosfamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.000436	CcSEcCtD
Ifosfamide—Infection—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000434	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.000433	CcSEcCtD
Ifosfamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.82e-05	0.000433	CcSEcCtD
Ifosfamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.82e-05	0.000433	CcSEcCtD
Ifosfamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.000428	CcSEcCtD
Ifosfamide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.71e-05	0.000428	CcSEcCtD
Ifosfamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000427	CcSEcCtD
Ifosfamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000427	CcSEcCtD
Ifosfamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.7e-05	0.000427	CcSEcCtD
Ifosfamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.66e-05	0.000425	CcSEcCtD
Ifosfamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.66e-05	0.000425	CcSEcCtD
Ifosfamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.64e-05	0.000424	CcSEcCtD
Ifosfamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.64e-05	0.000424	CcSEcCtD
Ifosfamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.63e-05	0.000424	CcSEcCtD
Ifosfamide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.000423	CcSEcCtD
Ifosfamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.6e-05	0.000422	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.00042	CcSEcCtD
Ifosfamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.54e-05	0.000419	CcSEcCtD
Ifosfamide—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.54e-05	0.000419	CcSEcCtD
Ifosfamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.53e-05	0.000418	CcSEcCtD
Ifosfamide—Nausea—Stavudine—acquired immunodeficiency syndrome	8.52e-05	0.000418	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000417	CcSEcCtD
Ifosfamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.000416	CcSEcCtD
Ifosfamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.42e-05	0.000413	CcSEcCtD
Ifosfamide—Nausea—Abacavir—acquired immunodeficiency syndrome	8.39e-05	0.000412	CcSEcCtD
Ifosfamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.37e-05	0.000411	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.00041	CcSEcCtD
Ifosfamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.35e-05	0.00041	CcSEcCtD
Ifosfamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.32e-05	0.000408	CcSEcCtD
Ifosfamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.31e-05	0.000408	CcSEcCtD
Ifosfamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.31e-05	0.000408	CcSEcCtD
Ifosfamide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.31e-05	0.000408	CcSEcCtD
Ifosfamide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.000407	CcSEcCtD
Ifosfamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.28e-05	0.000407	CcSEcCtD
Ifosfamide—Pain—Ritonavir—acquired immunodeficiency syndrome	8.28e-05	0.000407	CcSEcCtD
Ifosfamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.28e-05	0.000406	CcSEcCtD
Ifosfamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.28e-05	0.000406	CcSEcCtD
Ifosfamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.24e-05	0.000404	CcSEcCtD
Ifosfamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.2e-05	0.000402	CcSEcCtD
Ifosfamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.11e-05	0.000398	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.1e-05	0.000398	CcSEcCtD
Ifosfamide—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.07e-05	0.000396	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000395	CcSEcCtD
Ifosfamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.04e-05	0.000395	CcSEcCtD
Ifosfamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000392	CcSEcCtD
Ifosfamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.98e-05	0.000392	CcSEcCtD
Ifosfamide—Pain—Saquinavir—acquired immunodeficiency syndrome	7.97e-05	0.000391	CcSEcCtD
Ifosfamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.97e-05	0.000391	CcSEcCtD
Ifosfamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.93e-05	0.000389	CcSEcCtD
Ifosfamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.000389	CcSEcCtD
Ifosfamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.92e-05	0.000389	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.92e-05	0.000389	CcSEcCtD
Ifosfamide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.000388	CcSEcCtD
Ifosfamide—Rash—Zidovudine—acquired immunodeficiency syndrome	7.86e-05	0.000386	CcSEcCtD
Ifosfamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.86e-05	0.000386	CcSEcCtD
Ifosfamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.85e-05	0.000385	CcSEcCtD
Ifosfamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.75e-05	0.00038	CcSEcCtD
Ifosfamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.00038	CcSEcCtD
Ifosfamide—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.72e-05	0.000379	CcSEcCtD
Ifosfamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.7e-05	0.000378	CcSEcCtD
Ifosfamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.68e-05	0.000377	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000377	CcSEcCtD
Ifosfamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000376	CcSEcCtD
Ifosfamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.66e-05	0.000376	CcSEcCtD
Ifosfamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000376	CcSEcCtD
Ifosfamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000376	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000374	CcSEcCtD
Ifosfamide—Pain—Lamivudine—acquired immunodeficiency syndrome	7.61e-05	0.000373	CcSEcCtD
Ifosfamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.61e-05	0.000373	CcSEcCtD
Ifosfamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.52e-05	0.000369	CcSEcCtD
Ifosfamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.000368	CcSEcCtD
Ifosfamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.41e-05	0.000364	CcSEcCtD
Ifosfamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.41e-05	0.000364	CcSEcCtD
Ifosfamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.4e-05	0.000363	CcSEcCtD
Ifosfamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.000362	CcSEcCtD
Ifosfamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.000362	CcSEcCtD
Ifosfamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.37e-05	0.000362	CcSEcCtD
Ifosfamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.33e-05	0.00036	CcSEcCtD
Ifosfamide—Rash—Indinavir—acquired immunodeficiency syndrome	7.31e-05	0.000359	CcSEcCtD
Ifosfamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.3e-05	0.000358	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000357	CcSEcCtD
Ifosfamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.24e-05	0.000355	CcSEcCtD
Ifosfamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000352	CcSEcCtD
Ifosfamide—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.14e-05	0.00035	CcSEcCtD
Ifosfamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000347	CcSEcCtD
Ifosfamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000345	CcSEcCtD
Ifosfamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000345	CcSEcCtD
Ifosfamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.96e-05	0.000342	CcSEcCtD
Ifosfamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.95e-05	0.000341	CcSEcCtD
Ifosfamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.93e-05	0.00034	CcSEcCtD
Ifosfamide—Rash—Efavirenz—acquired immunodeficiency syndrome	6.9e-05	0.000339	CcSEcCtD
Ifosfamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.9e-05	0.000339	CcSEcCtD
Ifosfamide—Nausea—Indinavir—acquired immunodeficiency syndrome	6.88e-05	0.000338	CcSEcCtD
Ifosfamide—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.87e-05	0.000337	CcSEcCtD
Ifosfamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.85e-05	0.000336	CcSEcCtD
Ifosfamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000328	CcSEcCtD
Ifosfamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.66e-05	0.000327	CcSEcCtD
Ifosfamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000325	CcSEcCtD
Ifosfamide—Rash—Delavirdine—acquired immunodeficiency syndrome	6.61e-05	0.000324	CcSEcCtD
Ifosfamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.6e-05	0.000324	CcSEcCtD
Ifosfamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000324	CcSEcCtD
Ifosfamide—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.55e-05	0.000322	CcSEcCtD
Ifosfamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.5e-05	0.000319	CcSEcCtD
Ifosfamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.41e-05	0.000314	CcSEcCtD
Ifosfamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000313	CcSEcCtD
Ifosfamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000313	CcSEcCtD
Ifosfamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.29e-05	0.000309	CcSEcCtD
Ifosfamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.22e-05	0.000305	CcSEcCtD
Ifosfamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.17e-05	0.000303	CcSEcCtD
Ifosfamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.16e-05	0.000302	CcSEcCtD
Ifosfamide—Rash—Ritonavir—acquired immunodeficiency syndrome	6.11e-05	0.0003	CcSEcCtD
Ifosfamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.0003	CcSEcCtD
Ifosfamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000299	CcSEcCtD
Ifosfamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.93e-05	0.000291	CcSEcCtD
Ifosfamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.88e-05	0.000289	CcSEcCtD
Ifosfamide—Rash—Saquinavir—acquired immunodeficiency syndrome	5.88e-05	0.000289	CcSEcCtD
Ifosfamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000288	CcSEcCtD
Ifosfamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.75e-05	0.000282	CcSEcCtD
Ifosfamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.000278	CcSEcCtD
Ifosfamide—Rash—Lamivudine—acquired immunodeficiency syndrome	5.61e-05	0.000275	CcSEcCtD
Ifosfamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000275	CcSEcCtD
Ifosfamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.54e-05	0.000272	CcSEcCtD
Ifosfamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.28e-05	0.000259	CcSEcCtD
